CN101138741A - A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation - Google Patents

A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation Download PDF

Info

Publication number
CN101138741A
CN101138741A CNA2007100469902A CN200710046990A CN101138741A CN 101138741 A CN101138741 A CN 101138741A CN A2007100469902 A CNA2007100469902 A CN A2007100469902A CN 200710046990 A CN200710046990 A CN 200710046990A CN 101138741 A CN101138741 A CN 101138741A
Authority
CN
China
Prior art keywords
ionic liquid
pyridine ligand
organic solvent
ruthenium catalyst
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100469902A
Other languages
Chinese (zh)
Inventor
谢美然
马卓
孔毅
韩会景
王伟珍
史佳鑫
李金欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China Normal University
Original Assignee
East China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China Normal University filed Critical East China Normal University
Priority to CNA2007100469902A priority Critical patent/CN101138741A/en
Publication of CN101138741A publication Critical patent/CN101138741A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明涉及一种钌催化剂及其制备方法,特别涉及一种含吡啶配体的离子液体负载的钌催化剂及其制备方法,属于催化剂及其制备技术领域。将咪唑类离子液体与4-羟基吡啶反应得到含吡啶基团的咪唑类离子液体与[Ru]配位制得。制得的该钌催化剂由于含有离子液体部分而可以很好的溶解于极性溶剂特别是离子液体中,从而实现在纯离子液体中的开环易位聚合(ROMP)反应。该钌催化剂改善了现有的钌催化剂在极性溶剂中溶解性差的缺点,此催化剂可以溶解在极性溶剂如醇类、丙酮和离子液体中,进而实现在纯离子液体中的开环易位聚合反应,拓展了钌催化剂的应用范围。The invention relates to a ruthenium catalyst and a preparation method thereof, in particular to a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand and a preparation method thereof, belonging to the technical field of catalyst and preparation thereof. The imidazole ionic liquid is reacted with 4-hydroxypyridine to obtain the imidazole ionic liquid containing pyridine group and coordinated with [Ru]. The prepared ruthenium catalyst can be well dissolved in a polar solvent, especially an ionic liquid, because it contains an ionic liquid part, thereby realizing a ring-opening metathesis polymerization (ROMP) reaction in a pure ionic liquid. The ruthenium catalyst improves the disadvantage of poor solubility in polar solvents of existing ruthenium catalysts, and the catalyst can be dissolved in polar solvents such as alcohols, acetone, and ionic liquids, thereby realizing ring-opening metathesis in pure ionic liquids The polymerization reaction expands the application scope of ruthenium catalyst.

Description

一种含吡啶配体的离子液体负载的钌催化剂及其制备 A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation

技术领域technical field

本发明涉及一种钌催化剂及其制备方法,特别涉及一种含吡啶配体的离子液体负载的钌催化剂及其制备方法,属于催化剂及其制备技术领域。The invention relates to a ruthenium catalyst and a preparation method thereof, in particular to a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand and a preparation method thereof, belonging to the technical field of catalyst and preparation thereof.

背景技术Background technique

钌催化剂是开环易位聚合反应中影响单体聚合的重要因素。目前已有的Grubbs第一代和第二代催化剂由于具有良好的稳定性和官能团耐受性,可以进行活性聚合并得到结构明确的产物而成为广泛应用的催化剂。但Grubbs催化剂只在二氯甲烷、苯、甲苯等非极性溶剂中有良好的溶解性,在极性溶剂如醇类、水和离子液体中溶解性很差,而限制了其在极性溶剂中开环易位聚合(ROMP)反应的进行。Ruthenium catalyst is an important factor affecting monomer polymerization in ring-opening metathesis polymerization. The existing Grubbs first-generation and second-generation catalysts have become widely used catalysts due to their good stability and functional group tolerance, which can carry out living polymerization and obtain products with well-defined structures. But the Grubbs catalyst only has good solubility in nonpolar solvents such as methylene chloride, benzene, toluene, and has poor solubility in polar solvents such as alcohols, water and ionic liquids, and limits its use in polar solvents. in the ring-opening metathesis polymerization (ROMP) reaction.

发明内容Contents of the invention

本发明的目的在于克服目前已有的钌催化剂在极性溶剂中溶解性差的缺点,改善其在离子液体等极性溶剂中的溶解性,从而实现在纯离子液体环境中的聚合反应。The purpose of the present invention is to overcome the disadvantages of poor solubility of existing ruthenium catalysts in polar solvents, improve their solubility in polar solvents such as ionic liquids, so as to realize the polymerization reaction in a pure ionic liquid environment.

本发明的一种含吡啶配体的离子液体负载的钌催化剂的结构式如下:The structural formula of the ruthenium catalyst supported by a kind of ionic liquid containing pyridine ligand of the present invention is as follows:

Figure A20071004699000041
Figure A20071004699000041

上述式中,R1为BF4 -,PF6 -或CF3COO-;R2为H或甲基(-CH3);n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - ; R 2 is H or methyl (-CH 3 ); n is a natural number from 2 to 12, [Ru] is the first generation of Grubbs Catalyst or Grubbs second generation catalyst.

当R1为BF4 -,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is BF 4 , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:

Figure A20071004699000042
Figure A20071004699000042

当R1为BF4 -,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is BF 4 - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is :

Figure A20071004699000043
Figure A20071004699000043

当R1为PF6 -,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is PF 6 , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:

Figure A20071004699000051
Figure A20071004699000051

当R1为PF6 -,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is PF 6 - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is :

Figure A20071004699000052
Figure A20071004699000052

当R1为CF3COO-,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is CF 3 COO - , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:

Figure A20071004699000053
Figure A20071004699000053

当R1为CF3COO-,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is CF 3 COO - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, n=2, the ruthenium catalyst supported by ionic liquid containing pyridine ligand for:

Figure A20071004699000054
Figure A20071004699000054

本发明的一种含吡啶配体的离子液体负载的钌催化剂的制备方法,合成路线为:A kind of preparation method of the ruthenium catalyst supported by the ionic liquid containing pyridine ligand of the present invention, synthetic route is:

Figure A20071004699000055
Figure A20071004699000055

上述式中,X=Cl,Br,R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),Mt为Na或K,n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, X=Cl, Br, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), M t is Na or K, n is from 2 Natural numbers to 12, [Ru] is Grubbs first-generation catalyst or Grubbs second-generation catalyst.

本发明的一种含吡啶配体的离子液体负载的钌催化剂的制备方法,具体按照下列顺序、步骤进行:A kind of preparation method of the ruthenium catalyst supported by the ionic liquid containing pyridine ligand of the present invention, specifically carry out according to following order, step:

第一步:合成结构式如下的离子液体:Step 1: Synthesize an ionic liquid with the following structural formula:

上述式中,R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),n是从2到12的自然数。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), and n is a natural number from 2 to 12.

(1)将咪唑类化合物与卤代醇X-(CH2)n-OH按照摩尔比1∶1~1∶1.2反应,在有机溶剂中及氮气保护下,于60~120℃反应6~12小时,生成离子液体

Figure A20071004699000063
所述有机溶剂为苯或甲苯,其用量为5~8ml/g咪唑类化合物。(1) the imidazole compound React with haloalcohol X-(CH 2 ) n -OH at a molar ratio of 1:1 to 1:1.2, in an organic solvent and under the protection of nitrogen, and react at 60-120°C for 6-12 hours to generate an ionic liquid
Figure A20071004699000063
The organic solvent is benzene or toluene, and its dosage is 5-8ml/g imidazole compound.

(2)步骤(1)中所得的离子液体与盐按1∶1.2~1∶1.5的摩尔比,在水相或有机溶剂中,室温搅拌,反应时间为12~48小时。经过与盐的阴离子交换,得到离子液体

Figure A20071004699000064
所用盐为NaBF4,KPF6或CF3COONa。所述有机溶剂为丙酮、乙醇、乙腈或DMF,其用量为10~50ml/g离子液体。(2) The ionic liquid obtained in step (1) and the salt are stirred in an aqueous phase or an organic solvent at room temperature in a molar ratio of 1:1.2 to 1:1.5, and the reaction time is 12 to 48 hours. After anion exchange with salt, the ionic liquid is obtained
Figure A20071004699000064
The salts used were NaBF 4 , KPF 6 or CF 3 COONa. The organic solvent is acetone, ethanol, acetonitrile or DMF, and its dosage is 10-50ml/g ionic liquid.

(3)步骤(2)中得到的离子液体与对甲苯磺酰氯按1∶1~1∶1.2摩尔比,冰水浴下搅拌,反应时间为4~12小时,在有机溶剂和碱性试剂中制得离子液体的对甲苯磺酸酯所述有机溶剂为二氯甲烷或乙腈,用量为6~12ml/g离子液体。碱性试剂为三乙胺或吡啶,用量与对甲苯磺酰氯相同。得到的对甲苯磺酸酯再与4-羟基吡啶在碱的作用下反应,得到含离子液体的吡啶配体

Figure A20071004699000071
(3) The ionic liquid obtained in the step (2) and p-toluenesulfonyl chloride are in a molar ratio of 1:1 to 1:1.2, stirred under an ice-water bath, and the reaction time is 4 to 12 hours, prepared in an organic solvent and an alkaline reagent p-toluenesulfonate The organic solvent is dichloromethane or acetonitrile, and the dosage is 6-12ml/g ionic liquid. The basic reagent is triethylamine or pyridine, and the dosage is the same as that of p-toluenesulfonyl chloride. The obtained p-toluenesulfonate is then reacted with 4-hydroxypyridine under the action of a base to obtain a pyridine ligand containing an ionic liquid
Figure A20071004699000071

第二步:合成含吡啶配体的离子液体负载的钌催化剂:The second step: synthesis of ruthenium catalyst supported by ionic liquid containing pyridine ligand:

将1中所得的含离子液体的吡啶配体与与[Ru]按摩尔比5∶1~10∶1,优选摩尔比为8∶1,反应温度为室温,反应时间为1~4小时,在混合有机溶剂中制得含吡啶配体的离子液体负载的钌催化剂和含离子液体的吡啶配体的混合物。所述混合有机溶剂为二氯甲烷或丙酮和二氯甲烷的混合溶剂,优选摩尔比为丙酮∶二氯甲烷=1.2∶1。将此反应混合物抽干溶剂后经有机溶剂纯化处理,得到含吡啶配体的离子液体负载的钌催化剂

Figure A20071004699000072
所述有机溶剂为二氯甲烷、丙酮、正己烷。The pyridine ligand containing the ionic liquid obtained in 1 is mixed with [Ru] in a molar ratio of 5:1 to 10:1, preferably a molar ratio of 8:1, the reaction temperature is room temperature, and the reaction time is 1 to 4 hours. A mixture of the ruthenium catalyst supported by the ionic liquid containing the pyridine ligand and the pyridine ligand containing the ionic liquid is prepared in a mixed organic solvent. The mixed organic solvent is dichloromethane or a mixed solvent of acetone and dichloromethane, and the preferred molar ratio is acetone:dichloromethane=1.2:1. After the reaction mixture is drained of the solvent, it is purified by an organic solvent to obtain a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand
Figure A20071004699000072
Described organic solvent is dichloromethane, acetone, n-hexane.

上述式中R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), n is a natural number from 2 to 12, [Ru] is Grubbs first-generation catalyst Or Grubbs second-generation catalyst.

本发明的方法中,X表示卤素,优选氯和溴。In the process of the present invention, X represents halogen, preferably chlorine and bromine.

本发明的含吡啶配体的离子液体负载的钌催化剂经核磁共振方法检测,证实其为所述的钌催化剂。The ruthenium catalyst supported by the ionic liquid containing the pyridine ligand of the present invention is detected by the nuclear magnetic resonance method, and it is confirmed that it is the ruthenium catalyst.

有益效果:本发明的含吡啶配体的离子液体负载的钌催化剂改善了现有的钌催化剂在极性溶剂中溶解性差的缺点,此催化剂可以溶解在极性溶剂如醇类、丙酮和离子液体中,进而实现在纯离子液体中的开环易位聚合反应,拓展了钌催化剂的应用范围。Beneficial effect: the ruthenium catalyst supported by ionic liquid containing pyridine ligand of the present invention improves the disadvantage of poor solubility of existing ruthenium catalysts in polar solvents, and this catalyst can be dissolved in polar solvents such as alcohols, acetone and ionic liquids In this way, the ring-opening metathesis polymerization reaction in pure ionic liquids is realized, which expands the application range of ruthenium catalysts.

具体实施方式Detailed ways

本发明提供的实施例如下:Embodiments provided by the invention are as follows:

实施例1Example 1

1,2-二甲基-3-羟乙基咪唑氯离子液体(1)的合成Synthesis of 1,2-Dimethyl-3-hydroxyethylimidazolium Chloride Ionic Liquid (1)

Figure A20071004699000073
Figure A20071004699000073

向250ml反应瓶中加入1,2-二甲基咪唑(19.2g,200mmol)和氯乙醇(16.1ml,240mmol),用20ml甲苯溶解,110℃反应8小时,停止反应,静置,倒去上层甲苯。再用甲苯洗三次(20ml×3)。向粗产品中加入20ml丙酮,70℃回流搅拌30min,静置,倒去上层溶剂。重复用丙酮洗涤二次,静置,冷却,下层有浅黄色固体析出。将浅黄色粗产品用乙腈重结晶,得到白色晶体,真空干燥得到化合物1(27.5g,产率78%)。1H-NMR(D2O,δ):7.35(d,2H,N-CH=HC-N),4.22(t,2H,N-CH2),3.87(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),10.53(C-CH3)。Add 1,2-dimethylimidazole (19.2g, 200mmol) and chloroethanol (16.1ml, 240mmol) into a 250ml reaction flask, dissolve in 20ml of toluene, react at 110°C for 8 hours, stop the reaction, let it stand, and pour off the upper layer toluene. Then wash three times with toluene (20ml×3). Add 20ml of acetone to the crude product, stir at reflux at 70°C for 30min, let stand, and pour off the upper solvent. Repeat washing with acetone twice, let it stand, and cool down, and a light yellow solid is precipitated in the lower layer. The light yellow crude product was recrystallized from acetonitrile to obtain white crystals, which were dried in vacuo to obtain compound 1 (27.5 g, yield 78%). 1 H-NMR (D 2 O, δ): 7.35 (d, 2H, N-CH=HC-N), 4.22 (t, 2H, N-CH 2 ), 3.87 (t, 2H, CH 2 -OH) , 3.74 (s, 3H, N-CH 3 ), 2.56 (s, 3H, C-CH 3 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH) , 61.31 (CH2 - OH), 51.53 (N- CH2 ), 36.12 (N- CH3 ), 10.53 (C- CH3 ).

实施例2Example 2

1,2-二甲基-3-羟乙基六氟磷酸盐离子液体(2)的合成Synthesis of 1,2-Dimethyl-3-hydroxyethylhexafluorophosphate Ionic Liquid (2)

Figure A20071004699000081
Figure A20071004699000081

将KPF6(13.2g,72mmol)溶解在80ml水中,用冰水浴冷却,然后将化合物1(10.6g,60mmol)的50ml水溶液缓慢滴入。滴加完后逐渐升至室温反应12小时,停止反应。脱去溶剂水,得到浅黄色粘稠液体(含有白色固体)。用50ml丙酮溶解,过滤,滤液用无水硫酸钠干燥,脱掉溶剂后得无色粘稠液体,真空干燥,得到化合物2(14.2g,产率83%)。1H-NMR(D2O,δ):7.40(d,2H,HC=CH),4.27(t,2H,N-CH2),3.94(t,2H,CH2-OH),3.80(s,3H,N-CH3),2.62(s,3H,C-CH3);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),10.53(C-CH3);31P-NMR(D2O,δ):-144.4(PF6 -)。KPF 6 (13.2g, 72mmol) was dissolved in 80ml of water, cooled with an ice-water bath, and then a 50ml aqueous solution of compound 1 (10.6g, 60mmol) was slowly dropped into it. After the dropwise addition, the reaction was gradually raised to room temperature for 12 hours, and the reaction was stopped. The solvent water was removed to obtain a light yellow viscous liquid (containing white solid). Dissolved with 50ml of acetone, filtered, and the filtrate was dried with anhydrous sodium sulfate, and the solvent was removed to obtain a colorless viscous liquid, which was dried in vacuo to obtain compound 2 (14.2g, yield 83%). 1 H-NMR (D 2 O, δ): 7.40 (d, 2H, HC=CH), 4.27 (t, 2H, N-CH 2 ), 3.94 (t, 2H, CH 2 -OH), 3.80 (s , 3H, N-CH 3 ), 2.62 (s, 3H, C-CH 3 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 10.53 (C-CH 3 ); 31 P-NMR (D 2 O, δ): -144.4 (PF 6 - ).

实施例3Example 3

1,2-二甲基-3-对甲苯磺酸乙酯六氟磷酸盐咪唑离子液体(3)的合成Synthesis of 1,2-dimethyl-3-ethyl p-toluenesulfonate imidazolium ionic liquid (3)

Figure A20071004699000082
Figure A20071004699000082

氮气保护下,向250ml Schlenk反应瓶中加入2(5.72g,20mmol),用35ml乙腈溶解,然后加入三乙胺(3.4ml,24mmol),冰水浴冷却。对甲苯磺酰氯(4.58g,24mmol)用25mL乙腈溶解,冰浴条件下滴加。滴加完后,维持0-5℃反应1小时,再升至室温反应10小时,停止反应。过滤,脱掉溶剂,得固体和深色粘稠液,用100ml CH2Cl2溶解,水洗多次后,有机相用无水Na2SO4干燥。脱去CH2Cl2得棕黄色固体,将固体用丙酮∶乙醚=2∶1重结晶得浅黄色固体,真空干燥得到产物4.84g,产率55.5%。1H-NMR(CO(CD3)2,δ):7.76(2H,HC=CHim),7.57(2H,2×CHaryl-C-S),7.51(2H,2×CHaryl-C-CH3),4.68(2H,N-CH2),4.53(2H,CH2-O),3.96(3H,N-CH3),2.76(3H,N-C-CH3),2.48(3H,Caryl-CH3);13C-NMR(CO(CD3)2,δ):146.65(Caryl-CH3),146.49(C2im),133.33(Caryl-S),131.11(2×CHaryl-Caryl-CH3),128.62(2×CHaryl-Caryl-S),123.75(C4im),122.31(C5im),69.01(CH2-O),48.00(N-CH2),35.70(N-CH3),21.54(Caryl-CH3),9.91(C-CH3)。Under nitrogen protection, 2 (5.72g, 20mmol) was added to a 250ml Schlenk reaction flask, dissolved in 35ml of acetonitrile, then triethylamine (3.4ml, 24mmol) was added, cooled in an ice-water bath. p-Toluenesulfonyl chloride (4.58g, 24mmol) was dissolved in 25mL of acetonitrile and added dropwise under ice-bath conditions. After the dropwise addition, the reaction was maintained at 0-5°C for 1 hour, then raised to room temperature for 10 hours, and the reaction was stopped. Filter and remove the solvent to obtain solid and dark viscous liquid, which are dissolved in 100ml CH 2 Cl 2 and washed with water several times, and the organic phase is dried with anhydrous Na 2 SO 4 . The CH 2 Cl 2 was removed to obtain a brown-yellow solid, which was recrystallized from acetone:ether=2:1 to obtain a light-yellow solid, which was dried in vacuo to obtain 4.84 g of the product, with a yield of 55.5%. 1 H-NMR (CO(CD 3 ) 2 , δ): 7.76 (2H, HC=CHim), 7.57 (2H, 2×CH aryl -CS), 7.51 (2H, 2×CH aryl -C-CH 3 ) , 4.68(2H, N-CH 2 ), 4.53(2H, CH 2 -O), 3.96(3H, N-CH 3 ), 2.76(3H, NC-CH 3 ), 2.48(3H, Caryl -CH 3 ); 13 C-NMR (CO(CD 3 ) 2 , δ): 146.65 (C aryl -CH 3 ), 146.49 (C 2 im), 133.33 (C aryl -S), 131.11 (2×CH aryl -C aryl -CH 3 ), 128.62 (2×CH aryl -C aryl -S), 123.75 (C 4 im), 122.31 (C 5 im), 69.01 (CH 2 -O), 48.00 (N-CH 2 ), 35.70 ( N-CH 3 ), 21.54 (C aryl -CH 3 ), 9.91 (C-CH 3 ).

实施例4Example 4

1,2-二甲基-3-乙氧基吡啶六氟磷酸盐咪唑离子液体(4)的合成Synthesis of 1,2-Dimethyl-3-ethoxypyridine Hexafluorophosphate Imidazolium Ionic Liquid (4)

Figure A20071004699000091
Figure A20071004699000091

氮气保护下,向100ml Schlenk反应瓶中加入4-羟基吡啶(0.58g,6.05mmol)和碳酸钾(1.25g,9.08mmol),用20ml DMF溶解,升温至80℃反应5小时。然后滴加3(2.20g,5.00mmol)的DMF(10ml)溶液,80℃搅拌4d,停止反应,体系为棕褐色。冷却过滤,除去溶剂,加入30ml丙酮搅拌,过滤除去不溶物,脱去丙酮,剩余褐色固体用丙酮∶乙酸乙酯=1∶1重结晶,得淡黄色晶体,真空干燥得到产物0.78g,产率43%。1H-NMR(CO(CD3)2,δ):8.40(2H,2×CHPy-N),7.75-7.63(2H,CH=CHim),6.95(2H,2×CHPy-C-O),4.83(2H,N-CH2),4.57(2H,CH2-O),3.97(3H,N-CH3)),2.95(3H,N-C-CH3);13C-NMR:(CO(CD3)2,δ):165.46(CPy-O),152.63(2×CHPy-N),147.63(C2im),124.20(C4im),123.21(C5im),111.71(2×CHPy-C-O),67.62(CH2-O),49.02(N-CH2),36.27(N-CH3),10.70(C-CH3);EA(%):C39.73,H4.61,N11.73(calc:C39.68,H4.44,N11.57)。Under nitrogen protection, 4-hydroxypyridine (0.58g, 6.05mmol) and potassium carbonate (1.25g, 9.08mmol) were added into a 100ml Schlenk reaction flask, dissolved in 20ml DMF, and heated to 80°C for 5 hours. Then a DMF (10ml) solution of 3 (2.20g, 5.00mmol) was added dropwise, stirred at 80°C for 4d, the reaction was stopped, and the system was brown. Cool and filter, remove the solvent, add 30ml of acetone and stir, filter to remove insoluble matter, remove the acetone, and recrystallize the remaining brown solid with acetone:ethyl acetate=1:1 to obtain light yellow crystals, which are dried in vacuo to obtain 0.78g of the product. 43%. 1 H-NMR (CO(CD 3 ) 2 , δ): 8.40 (2H, 2×CH Py -N), 7.75-7.63 (2H, CH=CHim), 6.95 (2H, 2×CH Py -CO), 4.83 (2H, N-CH 2 ), 4.57 (2H, CH 2 -O), 3.97 (3H, N-CH 3 )), 2.95 (3H, NC-CH 3 ); 13 C-NMR: (CO(CD 3 ) 2 , δ): 165.46 (C Py -O), 152.63 (2×CH Py -N), 147.63 (C 2 im), 124.20 (C 4 im), 123.21 (C 5 im), 111.71 (2× CH Py -CO), 67.62 (CH 2 -O), 49.02 (N-CH 2 ), 36.27 (N-CH 3 ), 10.70 (C-CH 3 ); EA (%): C39.73, H4.61 , N11.73 (calc: C39.68, H4.44, N11.57).

实施例5Example 5

含吡啶配体的离子液体负载钌催化剂的合成(5)Synthesis of Ruthenium Catalysts Supported by Ionic Liquids Containing Pyridine Ligands(5)

Figure A20071004699000092
Figure A20071004699000092

高纯氮保护下,向10mL Schlenk管中加入配体4(145mg,0.40mmol),向另一支管中加入第二代Grubbs催化剂(44.2mg,0.050mmol),两管分别抽真空充氮气,置换三次。用1.2ml干燥脱氧的丙酮溶解配体4,用1ml干燥的CH2Cl2溶解催化剂,两支反应管经液氮冷冻-抽真空-充氮气-融化后,在氮气氛围下将催化剂溶液滴加到配体溶液中。常温下搅拌,体系逐渐由红棕色变墨绿色,反应4小时,停止反应。氮气保护下减压脱掉溶剂,得绿色固体。加入1ml CH2Cl2,溶液为黄绿色,不溶固体为绿色,静置,吸出上层清液,弃之。剩余固体分别用少许CH2Cl2和己烷洗涤一次,减压干燥得绿色固体(该固体为配体4和催化剂的混合物)。1H-NMR(CO(CD3)2,δ):16.27(1H,Ru=CH-Ph),9.36(1H,CH-Ru),7.97~8.11(CHPy),7.73~7.62(CHim=CHim),7.43~7.35(CHaryl),6.5(CHPy),5.94~5.91(CH2),5.54~5.51(CH2),4.80(CH2),4.54(CH2),4.00(N-CH3),2.97(C-CH3),2.88~2.71(CH3);13C-NMR:(CO(CD3)2,δ):212.64(N-CH-Ru),165.01(CPy-O),152.11(2×CHpy-N),146.63(C2im),141.64,138.57,130.35,129.94,128.87,124.39(C4im),124.11,123.59,123.46,122.53(C5im),118.57,111.34(2×CHPy-C-O),110.92,69.27,67.17(CH2-O),54.91,48.31(N-CH2),35.65(N-CH3),20.21,18.85,10.85(C-CH3),10.08;31P-NMR(CO(CD3)2,δ):-143.3(PF6 -);ICP:催化剂的含量为14wt%。Under the protection of high-purity nitrogen, ligand 4 (145 mg, 0.40 mmol) was added to a 10 mL Schlenk tube, and the second-generation Grubbs catalyst (44.2 mg, 0.050 mmol) was added to another tube. three times. Dissolve the ligand 4 with 1.2ml of dry deoxygenated acetone, dissolve the catalyst with 1ml of dry CH 2 Cl 2 , freeze the two reaction tubes with liquid nitrogen-vacuumize-fill with nitrogen-thaw, add the catalyst solution dropwise under nitrogen atmosphere into the ligand solution. Stirring at room temperature, the system gradually changed from reddish brown to dark green, reacted for 4 hours, and stopped the reaction. Under nitrogen protection, the solvent was removed under reduced pressure to obtain a green solid. Add 1ml CH 2 Cl 2 , the solution is yellow-green, and the insoluble solid is green, let stand, suck out the supernatant, and discard it. The remaining solid was washed once with a little CH 2 Cl 2 and hexane, and dried under reduced pressure to obtain a green solid (the solid is a mixture of ligand 4 and catalyst). 1 H-NMR (CO(CD 3 ) 2 , δ): 16.27 (1H, Ru=CH-Ph), 9.36 (1H, CH-Ru), 7.97-8.11 (CH Py ), 7.73-7.62 (CHim=CHim ), 7.43~7.35 (CH aryl ), 6.5 (CH Py ), 5.94~5.91 (CH 2 ), 5.54~5.51 (CH 2 ), 4.80 (CH 2 ), 4.54 (CH 2 ), 4.00 (N-CH 3 ), 2.97 (C-CH 3 ), 2.88~2.71 (CH 3 ); 13 C-NMR: (CO(CD 3 ) 2 , δ): 212.64 (N-CH-Ru), 165.01 (C Py -O) , 152.11 (2×CH py -N), 146.63 (C 2 im), 141.64, 138.57, 130.35, 129.94, 128.87, 124.39 (C 4 im), 124.11, 123.59, 123.46, 122.53 (C 5 im), 118.57, 111.34 (2×CH Py -CO), 110.92, 69.27, 67.17 (CH 2 -O), 54.91, 48.31 (N-CH 2 ), 35.65 (N-CH 3 ), 20.21, 18.85, 10.85 (C-CH 3 ), 10.08; 31 P-NMR (CO(CD 3 ) 2 , δ): -143.3 (PF 6 - ); ICP: The catalyst content is 14 wt%.

实施例6Example 6

1,2-二甲基-3-十二烷基醇咪唑溴离子液体(6)的合成Synthesis of 1,2-Dimethyl-3-dodecyl imidazolium bromide ionic liquid (6)

Figure A20071004699000101
Figure A20071004699000101

向250ml反应瓶中加入1,2-二甲基咪唑(9.6g,100mmol)和12-溴代十二醇(29.2g,110mmol),用40ml甲苯溶解,70℃反应8小时,停止反应,静置,倒去上层甲苯。再用甲苯洗三次(30ml×3)。向粗产品中加入40ml丙酮,70℃回流搅拌30min,静置,倒去上层溶剂。重复用丙酮洗涤二次,静置,冷却,下层有浅黄色固体析出。将浅黄色粗产品用乙腈重结晶,得到白色晶体,真空干燥得到化合物6(32.2g,产率89%)。1H-NMR(D2O,δ):7.35(d,2H,N-CH=HC-N),4.04(t,2H,N-CH2),3.50(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3),1.74(t,2H,N-CH2-CH2),1.53(t,2H,CH2-CH2-OH),1.43(t,2H,CH2-(CH2)2-OH),1.29(m,12H,N-(CH2)2-CH2);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH)),10.53(C-CH3)。Add 1,2-dimethylimidazole (9.6g, 100mmol) and 12-bromododecanol (29.2g, 110mmol) into the 250ml reaction flask, dissolve with 40ml toluene, react at 70°C for 8 hours, stop the reaction, and Set aside, pour off the upper layer of toluene. Then wash three times with toluene (30ml×3). Add 40ml of acetone to the crude product, stir at reflux at 70°C for 30min, let stand, and pour off the upper solvent. Repeat washing with acetone twice, let it stand, and cool down, and a light yellow solid is precipitated in the lower layer. The light yellow crude product was recrystallized from acetonitrile to obtain white crystals, which were dried in vacuo to obtain compound 6 (32.2 g, yield 89%). 1 H-NMR (D 2 O, δ): 7.35 (d, 2H, N-CH=HC-N), 4.04 (t, 2H, N-CH 2 ), 3.50 (t, 2H, CH 2 -OH) , 3.74(s, 3H, N-CH 3 ), 2.56(s, 3H, C-CH 3 ), 1.74(t, 2H, N-CH 2 -CH 2 ), 1.53(t, 2H, CH 2 -CH 2 -OH), 1.43 (t, 2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (m, 12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH ), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH)), 10.53 (C- CH3 ).

实施例7Example 7

1,2-二甲基-3-十二烷基醇六氟磷酸盐离子液体(7)的合成Synthesis of 1,2-Dimethyl-3-dodecanol Hexafluorophosphate Ionic Liquid (7)

Figure A20071004699000102
Figure A20071004699000102

将KPF6(13.2g,72mmol)溶解在80ml水中,用冰水浴冷却,然后将化合物6(13.2g,60mmol)的150ml水溶液缓慢滴入。滴加完后逐渐升至室温反应48小时,停止反应。脱去溶剂水,得到白色固体。用50ml CH2Cl2溶解,过滤,滤液用水洗涤(30ml×4),有机相用无水硫酸钠干燥,脱掉溶剂后得白色固体,真空干燥,得到化合物7(21.2g,产率83%)。1H-NMR(DMSO,δ):7.35(d,2H,N-CH=HC-N),4.04(t,2H,N-CH2),3.50(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3),1.74(t,2H,N-CH2-CH2),1.53(t,2H,CH2-CH2-OH),1.43(t,2H,CH2-(CH2)2-OH),1.29(m,12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH,30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH)),10.53(C-CH3)。KPF 6 (13.2g, 72mmol) was dissolved in 80ml of water, cooled with an ice-water bath, and then a 150ml aqueous solution of compound 6 (13.2g, 60mmol) was slowly added dropwise. After the dropwise addition, the reaction was gradually raised to room temperature for 48 hours, and the reaction was stopped. The solvent water was removed to obtain a white solid. Dissolved with 50ml CH 2 Cl 2 , filtered, the filtrate was washed with water (30ml×4), the organic phase was dried with anhydrous sodium sulfate, a white solid was obtained after removing the solvent, and dried in vacuo to obtain compound 7 (21.2g, yield 83% ). 1 H-NMR (DMSO, δ): 7.35 (d, 2H, N-CH=HC-N), 4.04 (t, 2H, N-CH 2 ), 3.50 (t, 2H, CH 2 -OH), 3.74 (s, 3H, N-CH 3 ), 2.56 (s, 3H, C-CH 3 ), 1.74 (t, 2H, N-CH 2 -CH 2 ), 1.53 (t, 2H, CH 2 -CH 2 - OH), 1.43 (t, 2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (m, 12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH, 30.4 (N -CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH)) , 10.53 (C—CH 3 ).

实施例8Example 8

1,2-二甲基-3-对甲苯磺酸十二烷基酯六氟磷酸盐咪唑离子液体(8)的合成Synthesis of 1,2-Dimethyl-3-dodecyl p-toluenesulfonate Imidazolium Hexafluorophosphate Ionic Liquid (8)

Figure A20071004699000111
Figure A20071004699000111

氮气保护下,向250ml Schlenk反应瓶中加入7(8.53g,20mmol),用35ml乙腈溶解,然后加入三乙胺(3.4ml,24mmol),冰水浴冷却。对甲苯磺酰氯(4.58g,24mmol)用25mL乙腈溶解,冰浴条件下滴加。滴加完后,维持0-5℃反应1小时,再升至室温反应24小时,停止反应。过滤,脱掉溶剂,得固体和深色粘稠液,用100ml CH2Cl2溶解,水洗多次后,有机相用无水Na2SO4干燥。脱去CH2Cl2得棕黄色固体,将固体用丙酮∶乙醚=2∶1重结晶得浅黄色固体,真空干燥得到产物6.40g,产率55.5%。1H-NMR(DMSO,δ):7.35(N-CH=HC-N),7.17(2×CHaryl-C-S),7.11(2×CHaryl-C-CH3),4.04(N-CH2),3.50(CH2-OH),3.74(3H,N-CH3),2.56(3H,C-CH3),2.34(3H,Caryl-CH3),1.74(2H,N-CH2-CH2),1.53(2H,CH2-CH2-OH),1.43(2H,CH2-(CH2)2-OH),1.29(12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):146.65(Caryl-CH3),146.36(N-C-N),135.33(Caryl-S),131.11(2×CHaryl-Caryl-CH3),128.62(2×CHaryl-Caryl-S),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),21.34(Caryl-CH3),10.53(C-CH3)。Under nitrogen protection, 7 (8.53g, 20mmol) was added to a 250ml Schlenk reaction flask, dissolved in 35ml of acetonitrile, then triethylamine (3.4ml, 24mmol) was added, cooled in an ice-water bath. p-Toluenesulfonyl chloride (4.58g, 24mmol) was dissolved in 25mL of acetonitrile and added dropwise under ice-bath conditions. After the dropwise addition, the reaction was maintained at 0-5°C for 1 hour, then raised to room temperature for 24 hours, and the reaction was stopped. Filter and remove the solvent to obtain solid and dark viscous liquid, which are dissolved in 100ml CH 2 Cl 2 and washed with water several times, and the organic phase is dried with anhydrous Na 2 SO 4 . The CH 2 Cl 2 was removed to obtain a brownish yellow solid, which was recrystallized from acetone:ether = 2:1 to obtain a light yellow solid, which was dried in vacuo to obtain 6.40 g of the product, with a yield of 55.5%. 1 H-NMR (DMSO, δ): 7.35 (N-CH=HC-N), 7.17 (2×CH aryl -CS), 7.11 (2×CH aryl -C-CH 3 ), 4.04 (N-CH 2 ), 3.50 (CH 2 -OH), 3.74 (3H, N-CH 3 ), 2.56 (3H, C-CH 3 ), 2.34 (3H, Caryl -CH 3 ), 1.74 (2H, N-CH 2 - CH 2 ), 1.53 (2H, CH 2 -CH 2 -OH), 1.43 (2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 146.65 (C aryl -CH 3 ), 146.36 (NCN), 135.33 (C aryl -S), 131.11 (2×CH aryl -C aryl -CH 3 ), 128.62 (2×C Haryl -C aryl -S), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH ), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2-OH), 21.34 (C aryl -CH 3 ), 10.53 (C-CH 3 ).

实施例9Example 9

1,2-二甲基-3-十二烷氧基吡啶六氟磷酸盐咪唑离子液体(9)的合成Synthesis of 1,2-Dimethyl-3-dodecyloxypyridinium Hexafluorophosphate Imidazolium Ionic Liquid (9)

Figure A20071004699000112
Figure A20071004699000112

氮气保护下,向100ml Schlenk反应瓶中加入4-羟基吡啶(0.58g,6.05mmol)和碳酸钾(1.25g,9.08mmol),用20ml DMF溶解,升温至80℃反应5小时。然后滴加8(2.91g,5.00mmol)的DMF(10ml)溶液,80℃搅拌4d,停止反应,体系为棕褐色。冷却过滤,除去溶剂,加入30ml丙酮搅拌,过滤除去不溶物,脱去丙酮,剩余褐色固体用丙酮∶乙酸乙酯=1∶1重结晶,得淡黄色晶体,真空干燥得到产物1.07g,产率43%。1H-NMR(DMSO,δ):8.25(2H,2×CHPy-N),7.35(2H,N-CH=HC-N),6.85(2H,2×CHPy-C-O),4.04(2H,N-CH2),3.50(2H,CH2-OH),3.74(3H,N-CH3),2.56(3H,C-CH3),1.74(2H,N-CH2-CH2),1.53(2H,CH2-CH2-OH),1.43(2H,CH2-(CH2)2-OH),1.29(12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):156.2(CPy-O),150.7(2×CHPy-N),146.36(N-C-N),123.76,122.39(HC=CH),100.71(2×CHPy-C-O),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),10.53(C-CH3)。Under nitrogen protection, 4-hydroxypyridine (0.58g, 6.05mmol) and potassium carbonate (1.25g, 9.08mmol) were added into a 100ml Schlenk reaction flask, dissolved in 20ml DMF, and heated to 80°C for 5 hours. Then a DMF (10ml) solution of 8 (2.91g, 5.00mmol) was added dropwise, stirred at 80°C for 4d, the reaction was stopped, and the system was brown. Cool and filter, remove the solvent, add 30ml of acetone and stir, filter to remove insoluble matter, remove the acetone, and recrystallize the remaining brown solid with acetone:ethyl acetate=1:1 to obtain light yellow crystals, which are dried in vacuo to obtain 1.07g of the product, the yield 43%. 1 H-NMR (DMSO, δ): 8.25 (2H, 2×CH Py -N), 7.35 (2H, N-CH=HC-N), 6.85 (2H, 2×CH Py- CO), 4.04 (2H , N-CH 2 ), 3.50 (2H, CH 2 -OH), 3.74 (3H, N-CH 3 ), 2.56 (3H, C-CH 3 ), 1.74 (2H, N-CH 2 -CH 2 ), 1.53(2H, CH2 - CH2- OH), 1.43(2H, CH2- ( CH2 ) 2 -OH), 1.29(12H, N-( CH2 ) 2 - CH2 ); 13C -NMR( DMSO, δ): 156.2 (C Py -O), 150.7 (2×CH Py -N), 146.36 (NCN), 123.76, 122.39 (HC=CH), 100.71 (2×CH Py -CO), 61.31 (CH 2 -OH), 51.53(N-CH 2 ), 36.12(N-CH 3 ), 32.2(CH 2 -CH 2 -OH), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3 (N-(CH 2 ) 3 -CH 2 ), 25.6 (CH 2 -(CH 2 ) 2 -OH), 10.53 (C-CH 3 ).

实施例10Example 10

含吡啶配体的离子液体负载钌催化剂的合成(10)Synthesis of Ruthenium Catalysts Supported by Ionic Liquids Containing Pyridine Ligands(10)

Figure A20071004699000121
Figure A20071004699000121

高纯氮保护下,向10ml Schlenk管中加入配体9(200mg,0.40mmol),向另一支管中加入第二代Grubbs催化剂(44.2mg,0.050mmol),两管分别抽真空充氮气,置换三次。用1.2ml干燥脱氧的丙酮溶解配体9,用1ml干燥的CH2Cl2溶解催化剂,两支反应管经液氮冷冻-抽真空-充氮气-融化后,在氮气氛围下将催化剂溶液滴加到配体溶液中。常温下搅拌,体系逐渐由红棕色变墨绿色,反应4小时,停止反应。氮气保护下减压脱掉溶剂,得绿色固体。加入1ml CH2Cl2,溶液为黄绿色,不溶固体为绿色,静置,吸出上层清液,弃之。剩余固体分别用少许CH2Cl2和己烷洗涤一次,减压干燥得绿色固体(该固体为配体9和催化剂的混合物)。1H-NMR(DMSO,δ):16.27(1H,Ru=CH-Ph),9.43(1H,CH-Ru),7.73~7.62(CHim=CHim),7.97~8.25(CHPy),7.43~7.35(CHaryl),6.85(CHPy),4.04(N-CH2),3.50(CH2-OH),3.94(N-CH3),2.88~2.71(CH3),2.56(3H,C-CH3),1.74(N-CH2-CH2),1.53(CH2-CH2-OH),1.43(CH2-(CH2)2-OH),1.29(N-(CH2)2-CH2);13C-NMR(DMSO,δ):212.64(N-CH-Ru),165.7(CPy-O),146.36(N-C-N),150.11(2×CHPy-N),123.76,122.39(HC=CH),100.74(2×CHPy-C-O),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),10.53(C-CH3)。31P-NMR(CO(CD3)2,δ):-143.3(PF6 -)。Under the protection of high-purity nitrogen, add ligand 9 (200mg, 0.40mmol) to the 10ml Schlenk tube, add the second-generation Grubbs catalyst (44.2mg, 0.050mmol) to the other branch tube, and vacuumize and fill the two tubes with nitrogen respectively. three times. Dissolve the ligand 9 with 1.2ml of dry deoxygenated acetone, dissolve the catalyst with 1ml of dry CH 2 Cl 2 , freeze the two reaction tubes with liquid nitrogen-vacuumize-fill with nitrogen-thaw, add the catalyst solution dropwise under nitrogen atmosphere into the ligand solution. Stirring at room temperature, the system gradually changed from reddish brown to dark green, reacted for 4 hours, and stopped the reaction. Under nitrogen protection, the solvent was removed under reduced pressure to obtain a green solid. Add 1ml CH 2 Cl 2 , the solution is yellow-green, and the insoluble solid is green, let stand, suck out the supernatant, and discard it. The remaining solid was washed once with a little CH 2 Cl 2 and hexane, and dried under reduced pressure to obtain a green solid (the solid is a mixture of ligand 9 and catalyst). 1 H-NMR (DMSO, δ): 16.27 (1H, Ru=CH-Ph), 9.43 (1H, CH-Ru), 7.73-7.62 (CHim=CHim), 7.97-8.25 (CH Py ), 7.43-7.35 (CH aryl ), 6.85 (CH Py ), 4.04 (N-CH 2 ), 3.50 (CH 2 -OH), 3.94 (N-CH 3 ), 2.88~2.71 (CH 3 ), 2.56 (3H, C-CH 3 ), 1.74(N-CH 2 -CH 2 ), 1.53(CH 2 -CH 2 -OH), 1.43(CH 2 -(CH 2 ) 2 -OH), 1.29(N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 212.64 (N-CH-Ru), 165.7 (C Py -O), 146.36 (NCN), 150.11 (2×CH Py -N), 123.76, 122.39 (HC =CH), 100.74 (2×CH Py -CO), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH), 30.4 (N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH ), 10.53 (C—CH 3 ). 31 P-NMR (CO(CD 3 ) 2 , δ): -143.3 (PF 6 - ).

Claims (5)

1. ionic liquid loaded ruthenium catalyst that contains pyridine ligand is characterized in that structural formula is as follows:
Figure A2007100469900002C1
R in the formula 1Be BF 4 -, PF 6 -Or CF 3COO -R 2Be H or methyl; N is from 2 to 12 natural number; [Ru] is Grubbs first generation catalyst or Grubbs second generation catalyst.
2. preparation method who contains the ionic liquid loaded ruthenium catalyst of pyridine ligand is characterized in that may further comprise the steps:
The first step: the composite structure formula is following contains ion liquid pyridine ligand:
R in the formula 1Be BF 4 -, PF 6 -Or CF 3COO -, R 2Be H or methyl, n is from 2 to 12 natural number;
Second step: the synthetic ionic liquid loaded ruthenium catalyst that contains pyridine ligand:
With containing of gained in the first step ion liquid pyridine ligand with [Ru] 5: 1 in molar ratio~10: 1 in mixed organic solvents, mixed organic solvents is the mixed solvent of acetone and carrene, mol ratio is an acetone: carrene=1.2: 1; Make ionic liquid loaded ruthenium catalyst that contains pyridine ligand and the mixture that contains ion liquid pyridine ligand,, obtain containing the ionic liquid loaded ruthenium catalyst of pyridine ligand through the organic solvent purification process.
3. the preparation method who contains the ionic liquid loaded ruthenium catalyst of pyridine ligand as claimed in claim 2, it is characterized in that containing ion liquid pyridine ligand is 8: 1 with [Ru] in molar ratio.
4. the preparation method who contains the ionic liquid loaded ruthenium catalyst of pyridine ligand as claimed in claim 2 is characterized in that the organic solvent that purifying is used is carrene, acetone or n-hexane.
5. the preparation method who contains the ionic liquid loaded ruthenium catalyst of pyridine ligand as claimed in claim 2 is characterized in that the first step contains the synthetic of ion liquid pyridine ligand and comprises the steps:
(1) with glyoxaline compound
Figure A2007100469900003C1
With halohydrin X-(CH 2) n-OH was according to 1: 1~1: 1.2 mol ratio, and reaction generates ionic liquid in organic solvent and under the nitrogen protection
Figure A2007100469900003C2
Wherein organic solvent is benzene or toluene, and X represents halogen;
(2) mol ratio that the ionic liquid and the salt of gained in (1) are pressed 1: 1.2~1: 1.5 is reacted in water or organic solvent, generates ionic liquid
Figure A2007100469900003C3
Used salt is NaBF 4, KPF 6Or CF 3COONa; Organic solvent is acetone, ethanol, acetonitrile or DMF;
(3) ionic liquid and the paratoluensulfonyl chloride of gained in (2) are pressed 1: 1~1: 1.2 mol ratio, ice-water bath (0~5 ℃) stirs down, makes ion liquid p-methyl benzenesulfonic acid ester in organic solvent and alkaline reagent
Figure A2007100469900003C4
Organic solvent is carrene, acetonitrile; Alkaline reagent is triethylamine or pyridine, and consumption is identical with paratoluensulfonyl chloride;
(4) with 4-pyridone and K 2CO 3By 1: 1.5~1: 3 mol ratio, reaction temperature was 60~80 ℃, reacts in organic solvent, makes phenol potassium; The ion liquid p-methyl benzenesulfonic acid ester of gained in (3) is splashed in the phenol potassium solution, and reaction temperature is 60~80 ℃, obtains containing ion liquid pyridine ligand; Reaction finishes the back to be handled with organic solvent, obtains the colourless crystallization product
Figure A2007100469900003C5
Organic solvent is an acetonitrile, DMF, acetone or ethyl acetate;
(5) gained in (4) is contained ion liquid pyridine ligand and [Ru] 5: 1 in molar ratio~10: 1, reaction temperature is a room temperature, and the reaction time is 1~4 hour, makes the ionic liquid loaded ruthenium catalyst that contains pyridine ligand in organic solvent
Figure A2007100469900003C6
Described organic solvent is the mixed solvent (1.2: 1) of carrene or acetone and carrene.
CNA2007100469902A 2007-10-12 2007-10-12 A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation Pending CN101138741A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100469902A CN101138741A (en) 2007-10-12 2007-10-12 A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100469902A CN101138741A (en) 2007-10-12 2007-10-12 A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation

Publications (1)

Publication Number Publication Date
CN101138741A true CN101138741A (en) 2008-03-12

Family

ID=39190942

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100469902A Pending CN101138741A (en) 2007-10-12 2007-10-12 A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation

Country Status (1)

Country Link
CN (1) CN101138741A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961661B (en) * 2009-07-22 2012-08-08 中国石油天然气股份有限公司 Organic metal catalyst for preparing cyclohexene by benzene hydrogenation and preparation method and application thereof
CN102671709A (en) * 2012-04-28 2012-09-19 温州大学 Supported type acidic ionic liquid catalyst and application thereof
CN102690291A (en) * 2012-01-17 2012-09-26 青岛科技大学 Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof
CN102755909A (en) * 2011-04-28 2012-10-31 中国石油天然气股份有限公司 Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof
JP2016003182A (en) * 2014-06-13 2016-01-12 トヨタ紡織株式会社 New ionic liquid, and method and apparatus for absorbing gas
CN111957344A (en) * 2020-08-31 2020-11-20 郑州中科新兴产业技术研究院 Ionic liquid modified oxygen reduction reaction catalyst and preparation method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961661B (en) * 2009-07-22 2012-08-08 中国石油天然气股份有限公司 Organic metal catalyst for preparing cyclohexene by benzene hydrogenation and preparation method and application thereof
CN102755909A (en) * 2011-04-28 2012-10-31 中国石油天然气股份有限公司 Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof
CN102755909B (en) * 2011-04-28 2014-08-06 中国石油天然气股份有限公司 Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof
CN102690291A (en) * 2012-01-17 2012-09-26 青岛科技大学 Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof
CN102690291B (en) * 2012-01-17 2014-07-30 青岛科技大学 Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof
CN102671709A (en) * 2012-04-28 2012-09-19 温州大学 Supported type acidic ionic liquid catalyst and application thereof
JP2016003182A (en) * 2014-06-13 2016-01-12 トヨタ紡織株式会社 New ionic liquid, and method and apparatus for absorbing gas
CN111957344A (en) * 2020-08-31 2020-11-20 郑州中科新兴产业技术研究院 Ionic liquid modified oxygen reduction reaction catalyst and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101138741A (en) A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation
CN107573370A (en) The method that supported copper ion chitosan microball catalysis prepares organoboron compound and β hydroxy compounds
CN103265420B (en) A kind of preparation method of aromatic diketone compound
CN103012361A (en) Supramolecular polymer material constructed by doubly bridging sulfonated calixarenes and preparation thereof
CN111187152B (en) A kind of method for catalyzing and synthesizing pseudo-ionone by alkaline immobilized ionic liquid
JP2009023996A (en) Bipyridine compound, transition metal complex and method for producing conjugated aromatic compound using the complex
JP2004517042A (en) Process for producing olefin-substituted aromatic or heteroaromatic
JP2009067779A (en) Transition metal complex and method for producing conjugated aromatic compound using the complex
CH641671A5 (en) PROCESS FOR THE PREPARATION OF 2- (6'-METHOXY-2'-NAFTIL) -PROPIONIC ACID.
CN106749411B (en) A kind of o-phenanthroline tetradentate ligands and the preparation method and application thereof
CN111018678B (en) Preparation method of high-purity 3-phenoxy bromopropane
CN108218798A (en) The preparation method of Apabetalone
CN108864173B (en) Process for converting substituted sodium aryl sulfinate to aryl tri-n-butyl tin
CN102049301A (en) High-efficiency ionic liquid and cross-linked polystyrene-supported palladium catalyst and application thereof
CN110790689A (en) A kind of synthetic method of 1,1-difluoro-2-isonitrile-ethylphenyl sulfone compounds
CN112028874B (en) Synthesis method of eritinib
CN107915653A (en) Catalysis ester and amine carry out the method that reaction prepares acid amides
CN111662147A (en) Process for preparing diynes and analogues thereof
CN101712697A (en) Ferrocene phosphinimine ligand containing imidazole salt group, preparation thereof and application in catalyzing asymmetric allyl substitution reaction
CN102626655B (en) Aldol reaction catalyst and preparation method and application thereof
WO2019119516A1 (en) Tetramethylspiroindene skeleton-based bisoxazoline ligand compound, intermediate thereof, preparation method therefor, and use thereof
CN116144034B (en) Metallic triangular supramolecules with near-infrared fluorescence, preparation methods and applications
CN115353468B (en) A kind of preparation method of p-toluenesulfonyloxy substituted tert-butyl oligoethylene glycol propionate
CN114805800B (en) A kind of preparation method and application of N-sulfonamide polymer
CN103342810A (en) Polyethylene glycol functionalized three-arm star-shaped ionic liquid and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication